Incompatible Inhibitory KIR Ligands Contribute To Lower Survival Rates in Leukemia Patients Receiving T-Replete Hematopoietic Cell Transplants (HCTs).
Year: 2005
Type: article
Study design: Observational Study
Source: Blood
Authors: J.Y. Sun, A. Dagis, M.M. Miller, J. Longmate, R. Rodriguez, L. Gaidulis, S.J. Forman, D. David
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2565734680
